C3orf64 activators would refer to a class of chemical agents specifically designed to interact with and increase the activity of the protein encoded by the human gene C3orf64, also known as Chromosome 3 Open Reading Frame 64. The precise biological function of C3orf64 is not widely characterized, but based on its designation as an open reading frame, it is presumed to be a protein-coding gene that may play a role in various cellular functions. The protein encoded by this gene could be involved in cellular signaling, gene regulation, or other critical cellular processes. Activators of C3orf64 would thus be molecules that either enhance the protein's natural activity or promote its stability within the cellular environment. The mechanism by which these activators function could vary; they might increase protein synthesis, prevent degradation, facilitate proper folding, help in the correct localization within the cell, or enhance the protein's interaction with other molecules or substrates.
The process of identifying and developing C3orf64 activators involves a combination of high-throughput screening, medicinal chemistry, and structure-based drug design. Initially, large libraries of compounds would be screened in vitro using assay systems designed to detect increases in the activity or quantity of the C3orf64 protein. Such assays might measure the direct enzymatic activity of C3orf64 if known, or might use proxy measures such as the upregulation of a reporter gene under the protein's control. Compounds that show promise in these screens would then be subject to further analysis to confirm their mechanism of action. This could include biophysical methods to assess the binding of activators to C3orf64, and elucidate the nature of any conformational changes that result. Structural studies, potentially using techniques such as X-ray crystallography or NMR spectroscopy, could provide detailed insight into the interaction sites and binding modes of these activators, facilitating the design of more potent and selective analogs. Through iterative cycles of design, synthesis, and testing, a series of C3orf64 activators could be refined, providing tools for dissecting the biological role of the C3orf64 protein and elucidating its function within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
High glucose levels can increase global O-GlcNAcylation, which may feedback to influence EOGT expression. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
Glucosamine is used in the biosynthesis of UDP-GlcNAc, the donor substrate of EOGT, potentially affecting its expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation and may indirectly affect O-GlcNAc levels, impacting EOGT expression. | ||||||
Isofagomine D-Tartrate | 957230-65-8 | sc-207767 sc-207767A sc-207767C sc-207767B | 5 mg 10 mg 50 mg 25 mg | $387.00 $724.00 $2015.00 $1223.00 | ||
Thiamet G inhibits O-GlcNAcase, which may increase O-GlcNAc levels and could upregulate EOGT as a compensatory response. | ||||||
(Z)-Pugnac | 132489-69-1 | sc-204415A sc-204415 | 5 mg 10 mg | $224.00 $380.00 | 3 | |
Similar to Thiamet G, PUGNAc is another O-GlcNAcase inhibitor that could affect EOGT expression by altering O-GlcNAc cycling. | ||||||
Azaserine | 115-02-6 | sc-29063 sc-29063A | 50 mg 250 mg | $312.00 $924.00 | 15 | |
Azaserine inhibits glutamine-fructose amidotransferase, which could alter the hexosamine biosynthesis pathway and EOGT expression. | ||||||
6-Diazo-5-oxo-L-norleucine | 157-03-9 | sc-227078 sc-227078A sc-227078B sc-227078C | 5 mg 25 mg 100 mg 250 mg | $88.00 $291.00 $926.00 $2195.00 | ||
DON is a glutamine antagonist that may disrupt the hexosamine biosynthesis pathway, potentially influencing EOGT expression. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, as part of NAD+, is involved in metabolism and can affect cellular processes, potentially altering EOGT expression. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog inhibits glycolysis and could create metabolic stress that affects EOGT expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can cause protein accumulation and stress, which might influence EOGT expression levels. | ||||||